Skip to main content

Table 1 History definitions for metabolic syndrome

From: Insulin-like growth factor-1 deficiency and metabolic syndrome

Definitions

Insulin

Body weight

Blood pressure

Lipids

Glucose

Others

Kylin (1923)

  

Hypertension

 

Hyperglycaemia

Gout

Vague (1947)

Diabetes

Central obesity

 

Atherosclerosis

 

Gout

EASD (1965)

Hyperglycaemia

Obesity

Hypertension

   

Raeven (1988) “syndrome X”

Insulin resistance

 

Hypertension

High TG levels, low HDL-c

Glucose intolerance

 

Kaplan (1989) “The Deadly Quartet”

 

Upper body obesity

Hypertension

Hypertriglyceridaemia

Glucose intolerance

 

WHO (1998)

High insulin levels, IFG or IGT

Plus any 2 of the following

Abdominal obesity: WHR >0.9 for men and >0.85 for women, BMI >30 kg/m2

BP ≥160/90 mmHg

TG ≥150 mg/dL, and/or HDL-c <35 mg/dL in men, <39 in women

 

Microalbuminuria: urinary excretion rate >20 mg/min or albumin: creatinine ratio >30 mg/g

EGIR (1999)

Plasma insulin > 75th percentile

Plus any 2 of the following

WC ≥94 cm for men and ≥80 for women

BP ≥140/90 mmHg or antihypertensive medication

TG ≥150 mg/dL and/or HDL-c <39 mg/dL in men or women

IGT or fasting glucose 6.1 mmol/L, but no diabetes

 

NCEP-ATPIII (2001)

None

3 or more of the following

WC ≥ 102 cm for men and ≥ 88 cm for women

BP ≥130/85 mmHg

TG ≥150 mg/dL or HDL-C <40 mg/dL for men, <50 mg/dL form women

FPG >110 mg/dL (includes diabetes)

 

AACE (2003)

IGT or IFG

Plus 2 of the following

BMI ≥25 kg/m2

BP ≥130/85 mmHg

TG ≥150 mg/dL and HDL-c <40 mg/dL for men, <50 for women

IGT or IFG (but no diabetes)

Other features of insulin resistancea

IDF (2006)

None

Central obesity as defined by ethnic/racial

Plus 2 of the following

BP ≥130 mmHg systolic or ≥85 mmHg diastolic, or under treatment

TG ≥150 mg/dL or under treatment, or HDL-c <40 mg/dL for men, <50 mg/dL for women

IFG ≥ 100 mg/dL (includes diabetes)

 

Harmonization definition (2009)

None

3 or more of the following

Enlarged WC according to population and country specific criteria

BP ≥130 mmHg systolic or ≥85 mmHg diastolic, or under treatment

TG ≥150 mg/dL and HDL-c <40 mg/dL for men, <50 for women, or under treatment

IFG ≥ 100 mg/dL, or under treatment

 
  1. IFG impaired fasting glucose, IGT impaired glucose tolerance, WHR waist-to-hip ratio, BMI body mass index, WC waist circumference, BP blood pressure, HDL-c high density lipoprotein cholesterol, TG triglycerides
  2. aFamily history of type 2 diabetes, polycystic ovary syndrome, sedentary lifestyle, advancing age, and ethnic groups susceptible to type 2 diabetes